Clinical trial
Comparison of Ketamine and Esketamine in Ambulatory Patients Treated for Fibromyalgia Syndrome in Pain Clinic. A Single-center, Prospective, Randomized, Double-blind, Crossover Study.
NCT04938713 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Charleroi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Ketamine and Esketamine in Ambulatory Patients Treated for Fibromyalgia Syndrome in Pain Clinic. A Single-center, Prospective, Randomized, Double-blind, Crossover Study.
- Lead sponsor
- Centre Hospitalier Universitaire de Charleroi
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 1, 2021
- Completion date
- September 30, 2022
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.